App-Quantinova.ai

RELATIONSHIP OF NEUROINFLAMMATION ACCORDING TO AGING PROCESS AND PATHOGENESIS OF ALZHEIMERs DISEASE

K. Lee - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and Inflammation

Vahid Eslami - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

High-Sensitivity C-Reactive Protein, Erythrocyte Sedimentation Rate and Lactic Acid Are Associated With Internal Carotid Artery Occlusion in Chinese Stroke Patients

Yongbo Zhang - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

A Preliminary Study of the Efficacy and Biology of Swedish Massage vs. Light Touch

Mark Rapaport - Anxiety Disorders Association of America (ADAA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

A 3-Year Follow-up Study of Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant, or Unresponsive to Nonsteroidal Anti-Inflammatory Drugs and/or Colchicine

Naomi Schlesinger - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

Triamcinolone acetonide

Staggering Rates of High C-Reactive Protein in Children and Adolescents with Severe Obesity Using Nationally Representative Data

Asheley Cockrell Skinner - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort

Codrina Ancuta - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Scleroderma

Glucocorticoid

Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

Peter C. Taylor - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Baricitinib, Methotrexate, or Baricitinib Plus Methotrexate in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Phase 3 Trial Results

Roy Fleischmann - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Baseline MRI and CRP As Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

Matthew A. Brown - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Non-radiographic axial spondyloarthritis

Etanercept

Beta Cells Function and Insulin Resistance during Tocilizumab Treatment in Non-Diabetic RA Patients: Results from a Single-Center Study

Gorica Ristic - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Tocilizumab

Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Treatment Results

Desiree van der Heijde - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Non-radiographic axial spondyloarthritis

Etanercept

Does the Cytokine Pattern, Including the IL23 IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?

Andrea Pluma-Sanjurjo - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Interleukin

Early Clinical Response Is a Better Predictor of Long-Term Remission Than Baseline Disease Characteristics Following Adalimumab Treatment in Peripheral Spondyloarthritis

Filip van Den Bosch - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Peripheral spondyloarthritis

Adalimumab

Periodontal Disease in Lupus Erythematosus and Cardiovascular Risk Factors

Maria Cecilia Goizueta - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Pulmonary arterial hypertension

Glucocorticoid

Prevalence and Risk-Factors for Asymptomatic Coronary-Artery Calcifications in Young Patients with Systemic Lupus Erythematosus

Juanita Romero-Diaz - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis in Anti-TNF-Naive Patients and Those Previously Exposed to Anti-TNF Therapy: 52-Week Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

Dominique Baeten - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

secukinumab

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

Dominique Baeten - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

secukinumab

Secukinumab Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing

Juergen Braun - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

secukinumab

The Effect of Erosive Status on Systemic Inflammatory Biomarkers in Hand Osteoarthritis

Alexander Mathiessen - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Osteoarthritis 2

N/A

Filters

1408 Abstracts